RVP — RETRACTABLE TECHNOLOGIES INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 946563 ·
Last close
$0.69
Market Cap
$20.66M
52W High
$0.75
52W Low
$0.60
ADV30
74,327
Next earnings
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 7,177,397 -838,408 -4,690,188 -4,225,170 137,595,357 2,765,893 67,503,121
Dec 2025 9,439,582 -1,529,857 -807,667 -2,348,090 142,630,289 2,588,625 68,255,272
Sep 2025 10,085,723 1,685,904 -3,654,042 371,047 146,434,200 3,444,538 69,653,482
Jun 2025 10,445,733 -107,090 -3,659,602 -87,471 147,090,406 3,044,986 70,623,124

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,064,378
Investing CF
$5,984,936
Financing CF
$-567,321
CapEx
$-535,644
Dividends Paid
$-230,444
Buybacks
$0
EPS Diluted TTM
$-0.41
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$13,872,917
Inventory
$17,188,397
Receivables
$8,212,226
ST Investments
$34,382,808
EBIT TTM
$-12,186,032
Pretax Income TTM
$-12,273,938
Interest Exp TTM
$87,906
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$37,148,436
EBITDA
$-13,924,058
Free Cash Flow
$-1,961,753
Enterprise Value
$-12,849,033
Total Cash
$35,617,920
Total Debt
$1,193,249
Shares Out
29,937,159
Trailing EPS
$-0.22
Book Value
$2.33
ROE
-8.6%
ROA
-9.5%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 38,266,211 -14,269,299 -12,565,230 142,630,289 68,255,272 -7,064,378
Dec 2024 33,049,533 -15,204,582 -11,886,524 160,724,202 73,553,511 -11,557,036
Dec 2023 43,596,926 -5,264,318 -7,011,036 179,672,212 80,384,553 2,766,848
Dec 2022 94,818,938 2,979,771 5,078,557 195,665,665 89,128,856 16,768,128

Peers — same industry

TickerNameMarket CapLastDaily %
LFWD Lifeward Ltd. $19.39M $6.98
ICCM IceCure Medical Ltd. $18.40M $0.23
GTHP GUIDED THERAPEUTICS INC $18.34M $0.19
IRIX IRIDEX CORP $18.10M $1.04
OSRH OSR Holdings, Inc. $17.38M $0.50

News headlines (Yahoo Finance, 1h cache)

Retractable Stock Slips Post Q1 Earnings, Sales Decline Y/Y
2026-05-21 16:58 · Yahoo
Retractable Technologies, Inc. Results for the Period Ended March 31, 2026
2026-05-15 20:19 · Yahoo
Retractable Technologies, Inc. Announces Workforce Reduction
2026-04-09 21:46 · Yahoo
RVP Stock Plunges Post Q4 Earnings Despite Revenue Growth
2026-04-01 16:16 · Yahoo
Retractable Technologies, Inc. Reports Results for 2025
2026-03-27 21:04 · Yahoo
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
2026-03-27 20:59 · Yahoo
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures
2025-11-20 14:41 · Yahoo
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2025
2025-11-14 20:13 · Yahoo
Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle
2025-11-14 19:49 · Yahoo
Retractable Technologies Stock Gains Following Q2 Earnings Growth
2025-08-21 18:47 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.